These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 7523449

  • 1. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
    Conley ME, Larché M, Bonagura VR, Lawton AR, Buckley RH, Fu SM, Coustan-Smith E, Herrod HG, Campana D.
    J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
    [Abstract] [Full Text] [Related]

  • 2. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
    Durandy A, Schiff C, Bonnefoy JY, Forveille M, Rousset F, Mazzei G, Milili M, Fischer A.
    Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
    [Abstract] [Full Text] [Related]

  • 3. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
    Durandy A, Hivroz C, Mazerolles F, Schiff C, Bernard F, Jouanguy E, Revy P, DiSanto JP, Gauchat JF, Bonnefoy JY, Casanova JL, Fischer A.
    J Immunol; 1997 Mar 15; 158(6):2576-84. PubMed ID: 9058789
    [Abstract] [Full Text] [Related]

  • 4. Hyper IgM syndrome: two mutations distinguish HIM.
    Foy TM, Masters SR, Noelle RJ.
    J Clin Invest; 1994 Oct 15; 94(4):1349-50. PubMed ID: 7523448
    [No Abstract] [Full Text] [Related]

  • 5. CD40 ligand and its role in X-linked hyper-IgM syndrome.
    Callard RE, Armitage RJ, Fanslow WC, Spriggs MK.
    Immunol Today; 1993 Nov 15; 14(11):559-64. PubMed ID: 7506037
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
    Saiki O, Tanaka T, Wada Y, Uda H, Inoue A, Katada Y, Izeki M, Iwata M, Nunoi H, Matsuda I.
    J Clin Invest; 1995 Feb 15; 95(2):510-4. PubMed ID: 7532185
    [Abstract] [Full Text] [Related]

  • 10. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
    Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, Clark EA.
    J Immunol; 1994 Jun 15; 152(12):5643-52. PubMed ID: 7515910
    [Abstract] [Full Text] [Related]

  • 11. CD40 ligand/CD40 deficiency.
    Castigli E, Fuleihan R, Ramesh N, Tsitsikov E, Tsytsykova A, Geha RS.
    Int Arch Allergy Immunol; 1995 Jun 15; 107(1-3):37-9. PubMed ID: 7542090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The CD40 antigen and its ligand.
    Banchereau J, Bazan F, Blanchard D, Brière F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S.
    Annu Rev Immunol; 1994 Jun 15; 12():881-922. PubMed ID: 7516669
    [Abstract] [Full Text] [Related]

  • 14. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.
    Lin Q, Rohrer J, Allen RC, Larché M, Greene JM, Shigeoka AO, Gatti RA, Derauf DC, Belmont JW, Conley ME.
    J Clin Invest; 1996 Jan 01; 97(1):196-201. PubMed ID: 8550833
    [Abstract] [Full Text] [Related]

  • 15. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J, de Rijk D, Kasran A, Barcy S, de Groot C, de Boer M.
    Eur J Immunol; 1994 Mar 01; 24(3):508-17. PubMed ID: 7510232
    [Abstract] [Full Text] [Related]

  • 16. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells.
    Facchetti F, Appiani C, Salvi L, Levy J, Notarangelo LD.
    J Immunol; 1995 Jun 15; 154(12):6624-33. PubMed ID: 7539026
    [Abstract] [Full Text] [Related]

  • 17. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM.
    Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2170-3. PubMed ID: 7681587
    [Abstract] [Full Text] [Related]

  • 18. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
    Aversa G, Punnonen J, Carballido JM, Cocks BG, de Vries JE.
    Semin Immunol; 1994 Oct 15; 6(5):295-301. PubMed ID: 7532459
    [Abstract] [Full Text] [Related]

  • 19. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.
    Agematsu K, Nagumo H, Shinozaki K, Hokibara S, Yasui K, Terada K, Kawamura N, Toba T, Nonoyama S, Ochs HD, Komiyama A.
    J Clin Invest; 1998 Aug 15; 102(4):853-60. PubMed ID: 9710455
    [Abstract] [Full Text] [Related]

  • 20. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
    Razanajaona D, van Kooten C, Lebecque S, Bridon JM, Ho S, Smith S, Callard R, Banchereau J, Brière F.
    J Immunol; 1996 Aug 15; 157(4):1492-8. PubMed ID: 8759730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.